Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ziegler

Showing results (131-140 of 317) with videos related to

Pageof 32
Sort By:
Reviews in Clinical and Experimental Hematology|August 7, 2001
Purification and functional assay of pluripotent hematopoietic stem cellsC Peschle, R Botta, R Müller, et al.
Cancer|August 1, 1970
Cyclophosphamide toxicity in Ugandan and American patients with malignant lymphomaC H Brown, J L Ziegler, C Templeton, et al.
International Journal of Molecular Sciences|July 2, 2021
Probiotics, Prebiotics and Epithelial Tight Junctions: A Promising Approach to Modulate Intestinal Barrier FunctionElizabeth C Rose, Jack Odle, Anthony T Blikslager, et al.
Epilepsia|May 1, 1986
Partial epilepsy in neurologically normal children: clinical syndromes and prognosisT Deonna, A L Ziegler, P A Despland, et al.
European Journal of Cancer|March 1, 1974
Cell kinetics in Burkitt lymphomaO H Iversen, U Iversen, J L Ziegler, et al.
Cancer Treatment Reports|February 1, 1979
Phase II trial of adriamycin in carcinoma of the bilharzial bladderN Gad-el-Mawla, R Hamza, E Chevlen, et al.
Cancer Chemotherapy Reports|April 1, 1971
Clinical trials of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) given intravenously in the treatment of malignant melanoma in UgandaC L Vogel, R Comis, J L Ziegler, et al.
Experimental Gerontology|April 10, 1999
Finite lifespans of T cell clones derived from CD34+ human haematopoietic stem cells in vitroG Pawelec, R Müller, A Rehbein, et al.
Lancet (London, England)|January 17, 1970
Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cellsL Fass, R B Herberman, J L Ziegler, et al.
Cancer Treatment Reports|July 1, 1978
Phase II trial of bleomycin in bilharzial bladder cancerN Gad-el-Mawla, R Hamsa, E Chevlen, et al.
Pageof 32

Showing results (131-140 of 317) with videos related to

Sort By:
Pageof 32
Reviews in Clinical and Experimental Hematology|August 7, 2001
Purification and functional assay of pluripotent hematopoietic stem cellsC Peschle, R Botta, R Müller, et al.
Cancer|August 1, 1970
Cyclophosphamide toxicity in Ugandan and American patients with malignant lymphomaC H Brown, J L Ziegler, C Templeton, et al.
International Journal of Molecular Sciences|July 2, 2021
Probiotics, Prebiotics and Epithelial Tight Junctions: A Promising Approach to Modulate Intestinal Barrier FunctionElizabeth C Rose, Jack Odle, Anthony T Blikslager, et al.
Epilepsia|May 1, 1986
Partial epilepsy in neurologically normal children: clinical syndromes and prognosisT Deonna, A L Ziegler, P A Despland, et al.
European Journal of Cancer|March 1, 1974
Cell kinetics in Burkitt lymphomaO H Iversen, U Iversen, J L Ziegler, et al.
Cancer Treatment Reports|February 1, 1979
Phase II trial of adriamycin in carcinoma of the bilharzial bladderN Gad-el-Mawla, R Hamza, E Chevlen, et al.
Cancer Chemotherapy Reports|April 1, 1971
Clinical trials of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) given intravenously in the treatment of malignant melanoma in UgandaC L Vogel, R Comis, J L Ziegler, et al.
Experimental Gerontology|April 10, 1999
Finite lifespans of T cell clones derived from CD34+ human haematopoietic stem cells in vitroG Pawelec, R Müller, A Rehbein, et al.
Lancet (London, England)|January 17, 1970
Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cellsL Fass, R B Herberman, J L Ziegler, et al.
Cancer Treatment Reports|July 1, 1978
Phase II trial of bleomycin in bilharzial bladder cancerN Gad-el-Mawla, R Hamsa, E Chevlen, et al.
Pageof 32